Early-Onset CRC: A New Epidemic With Knowns and Unknowns

Ibrahim Sahin

How Recent Data Impacts Pancreatic Cancer Management

Integrity CE

M. Pishvaian

Pancreatic Cysts - Guidelines Based Management

AdventHealth

V. Shami

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

ESMO 2024 Insights: Treatment Rechallenge After Grade 1 Trastuzumab-…

2024 ESMO Annual Meeting Insights Hub

K. Natsuhara

Vogl,NY on How to Ask Good Questions at Medical Meetings

Vogl, NY

S. Vogl

Cancer Screening Molecular Tools

Fengting Yan

Year in Review: Colorectal Cancer

Moffitt Cancer Center

R. Kim, T. Biachi

Recent Updates in Upper Gl Cancers

Integrity CE

S. Mukherjee

The Importance of 1L Biomarkers in CRC

Nicholas DeVito

Young Onset Colorectal Cancer: A New Epidemic?

Ibrahim Sahin

ESMO 2024 Summary: Late-Line Therapy in mCRC - How to Choose

2024 ESMO Annual Meeting Insights Hub

H. Hochster

ASCO® 2024 Insights: "The GIANT Trial (EA2186) - Gem & nab-Paclitaxe…

2024 ASCO® Annual Meeting Insights Hub

E. Dotan

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

Neuroendocrine Tumors: Management and Updates

Integrity CE

R. Iyer

ASCO® 2023 Summary: "GI Key Studies Including PROSPECT, HERIZON-BTC-…

Insights from 2023 ASCO® Annual Meeting

R. Kim, R. Mehta

Debates in Neoadjuvant Therapy in Resectable Pancreatic Cancer: Why …

Integrity CE

L. Zheng

GI Cancers: Hot Topics in 2024

Yale Cancer Center

J. Lacy

ESMO 2024 Summary: Selecting 1L Therapy and Sequencing After Immunot…

2024 ESMO Annual Meeting Insights Hub

L. Rimassa

Colon Polyp with Carcinoma In-Situ, Intramucosal Cancer or Invasive …

Florida Gastroenterologic Society

D. Yang